KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Revenue (2016 - 2025)

Tenet Healthcare's Revenue history spans 17 years, with the latest figure at $5.5 billion for Q4 2025.

  • For Q4 2025, Revenue rose 8.84% year-over-year to $5.5 billion; the TTM value through Dec 2025 reached $21.3 billion, up 3.07%, while the annual FY2025 figure was $21.3 billion, 3.07% up from the prior year.
  • Revenue for Q4 2025 was $5.5 billion at Tenet Healthcare, up from $5.3 billion in the prior quarter.
  • Across five years, Revenue topped out at $5.5 billion in Q4 2025 and bottomed at $4.6 billion in Q2 2022.
  • The 5-year median for Revenue is $5.1 billion (2023), against an average of $5.1 billion.
  • The largest annual shift saw Revenue skyrocketed 35.8% in 2021 before it decreased 6.38% in 2022.
  • A 5-year view of Revenue shows it stood at $4.9 billion in 2021, then grew by 2.76% to $5.0 billion in 2022, then rose by 8.12% to $5.4 billion in 2023, then decreased by 5.88% to $5.1 billion in 2024, then grew by 8.84% to $5.5 billion in 2025.
  • Per Business Quant, the three most recent readings for THC's Revenue are $5.5 billion (Q4 2025), $5.3 billion (Q3 2025), and $5.3 billion (Q2 2025).